Related by context. All words. (Click for frequent words.) 75 retrospective cohort 74 prospective cohort 73 retrospective observational study 71 observational cohort study 71 longitudinal cohort study 71 prospective observational 70 multicenter study 69 multicentre study 69 substudy 69 Carotid Revascularization Endarterectomy vs. 69 retrospectively analyzed 66 randomized controlled trial 66 Stenting Trial CREST 66 Prostate Lung Colorectal 66 Digital Mammographic Imaging 66 Netherlands Cohort Study 65 multicenter randomized clinical 65 observational study 65 prospective nonrandomized 65 prospective longitudinal 65 liver transplant recipients 65 subanalysis 65 prospective observational cohort 65 Swedish Mammography Cohort 65 prospective multicenter study 65 metaanalysis 64 randomized clinical 64 Screening Trial 64 underwent CABG 64 prospective multicentre 64 Multicenter AIDS 63 undergone radical prostatectomy 63 longitudinal observational study 63 multicentre prospective 63 multiple logistic regression 63 Screening Trial DMIST 63 ExTRACT TIMI 63 multivariate analyzes 63 CaPSURE 63 randomized controlled trials RCTs 63 RE LY ® 63 randomized multicenter trial 63 multicentre 63 multicenter prospective 63 longitudinal study 63 multivariate logistic regression 63 Framingham Offspring Study 62 prospective randomized controlled 62 trials RCTs 62 PROactive study 62 Multiethnic Cohort Study 62 REALITY Trial 62 NHANES III 62 HORIZONS AMI trial 62 symptomatic BPH 62 INTERHEART study 62 NSABP B 62 conducted retrospective cohort 62 histologically confirmed 62 recurrent malignant glioma 62 Multivariate logistic regression 62 meta regression 62 multicenter randomized controlled 62 logistic regression analysis 61 logistic regression analyzes 61 undergoing coronary angiography 61 PLCO 61 Atherosclerosis Risk 61 perinatal outcomes 61 multicenter 61 STEP BD 61 patients undergoing CABG 61 Subgroup analyzes 61 logistic regression models 61 SEER registries 61 Intervention Trial 61 placebo controlled clinical 61 retrospectively reviewed 61 NICE SUGAR 61 atherothrombotic disease 61 SEER database 61 conditional logistic regression 61 genomewide association study 61 histologically proven 61 meta analysis 61 ACUITY trial 61 observational cohort 61 Phase IIIb study 60 Cohort Study 60 renal biopsy 60 prospective observational studies 60 NHAMCS 60 transrectal ultrasound guided 60 TG MV 60 underwent bariatric surgery 60 nulliparous women 60 Group RTOG 60 prospectively enrolled 60 transcatheter aortic valve implantation 60 hepatectomy 60 multicentric 60 dietary questionnaires 60 EBUS FNA 60 Kaplan Meier analysis 60 HealthGrades analyzed 60 Univariate analysis 60 prostate cancer CaP 60 randomized controlled clinical 60 anthropometric measurements 60 Intervention Effectiveness CATIE 60 singleton pregnancies 60 clinicopathologic 60 underwent liver transplantation 60 PARTNER Trial 60 congenital toxoplasmosis 60 randomized blinded 60 TAXUS ARRIVE 60 venous thromboembolic disease 60 subgroup analyzes 60 adenotonsillectomy 60 Multi Ethnic Study 60 DMIST 60 antiretroviral naïve 60 Nationwide Inpatient Sample 60 Ovarian PLCO Cancer 59 CARDIA 59 ELBW infants 59 prospective multicenter 59 underwent resection 59 RE LY trial 59 Intervention Trial GAIT 59 bowel capsule endoscopy 59 CALGB 59 multicenter multinational 59 chemoprevention trials 59 BARI 2D 59 multivariable analyzes 59 myocardial infarctions MIs 59 Framingham Offspring 59 Study AREDS 59 nonrandomized 59 postintervention 59 bivariate analyzes 59 Atherosclerosis MESA 59 cerebral microbleeds 59 SYNTAX trial 59 Val HeFT 59 System USRDS 59 polyarticular 59 randomized trials 59 REGARDS 59 Coronary artery bypass graft 59 IPAH 59 prospectively randomized 59 End Results SEER 59 SEER registry 59 logistic regression model 59 Coronary Artery Bypass Graft 59 METHODS 59 multivariable analysis 59 clinicopathological 59 Normative Aging Study 59 treatment naive genotype 59 VADT 59 carotid artery stenting CAS 59 Randomized controlled 59 Multiple logistic regression 59 Communities ARIC study 59 beta carotene supplementation 59 comorbid psychiatric disorders 59 diagnostic angiography 59 urolithiasis 59 CARDIA study 59 prospective randomized multicenter 59 nondiabetic patients 59 Millennium Cohort Study 59 clinico pathological 59 univariate 59 Prostate Cancer Prevention 59 NAMCS 59 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 59 chest radiographs 59 Arch Intern Med 58 Ovarian Cancer Screening 58 adnexal mass 58 psychiatric comorbidities 58 multicentre randomized 58 CIMZIA TM certolizumab pegol 58 symptomatic VTE 58 HYVET 58 Acute Decompensated Heart Failure 58 limiting generalizability 58 coinfected patients 58 Clinical Antipsychotic Trials 58 ILLUSTRATE 58 preoperative evaluation 58 nephron sparing surgery 58 underwent radical prostatectomy 58 HIV HCV coinfected 58 postoperative AF 58 diagnostic coronary angiography 58 angiographically 58 laparoscopic bariatric surgery 58 Multiethnic Study 58 liver transplantations 58 hip resurfacing arthroplasty 58 abdominal ultrasounds 58 prospective randomized 58 liver resection 58 randomized controlled clinical trials 58 Edge STudy 58 preoperative MRI 58 engineered urethras 58 FDG-PET/CT 58 prescribed antipsychotics 58 nodal metastasis 58 Echocardiographic 58 Skin sterol 58 epidemiologic studies 58 underwent coronary angiography 58 Observational Study 58 NMIBC 58 radical cystectomy 58 arteriography 58 underwent surgical resection 58 CHAMPION PCI 58 T1DM 58 NSQIP 58 atherogenic dyslipidemia 58 phase IIIb 58 NSTE ACS 58 randomized controlled 58 preintervention 58 hepatic resection 58 inguinal hernia repair 58 Alpha Tocopherol Beta Carotene 58 multicenter phase 58 relapsed MM 58 AIR2 Trial 58 prognostic variables 58 CABG surgeries 58 randomized placebo controlled 58 randomized 58 urodynamic 58 radical nephrectomy 58 peritoneal cancer 58 SWOG 58 phase IIb study 58 recurrent glioblastoma multiforme 58 thrombophilia 58 Stenting Trial 58 relapsing remitting MS RRMS 58 HCV SPRINT 57 AIR CF1 57 multivariate Cox 57 bariatric procedures 57 journal Ophthalmology 57 duplex ultrasonography 57 CARE HF 57 HIV seronegative 57 Gynecologic Oncology Group 57 STRIDE PD 57 Nutrition EPIC 57 BERKELEY CA UroToday.com 57 familial aggregation 57 Subgroup analysis 57 overnight polysomnography 57 resected pancreatic cancer 57 multicenter clinical 57 RE LY 57 double blinded randomized 57 diabetes mellitus DM 57 postoperative atrial fibrillation 57 carotid stenosis 57 undergoing radical prostatectomy 57 HeFT 57 UKPDS 57 DES implantation 57 peripartum 57 papillary renal cell carcinoma 57 immunohistochemical analysis 57 de novo AML 57 core needle biopsies 57 number NCT# ClinicalTrials.gov 57 landmark ATHENA 57 elective PCI 57 PREVENT IV 57 blind randomized controlled 57 Sociodemographic 57 blinded randomized placebo controlled 57 MADIT II 57 Surveillance Epidemiology 57 neoadjuvant treatment 57 randomized controlled trials 57 placebo controlled Phase III 57 pancreatic resection 57 postexposure prophylaxis 57 GPRD 57 coronary angiograms 57 Twin Registry 57 IMPROVE HF 57 Vertos II 57 multivariate regression analysis 57 computed tomographic 57 F FDG PET 57 Dialysis Outcomes 57 renal transplants 57 HCUP 57 placebo controlled trials 57 comorbidity 57 longitudinal studies 57 pelvic lymphadenectomy 57 randomized crossover 57 ConclusionThis 57 Multivariate analysis 57 TNM staging 57 β blockers 57 Birth Cohort 57 WHEL 57 practitioners internists 57 LNG IUS 57 prospectively evaluated 57 coronary CTA 57 ACS NSQIP 57 AVERROES 57 THIS STUDY 57 psychiatric morbidity 57 thromboprophylaxis 57 psychiatric outpatients 57 gallstone disease 57 univariate analyzes 57 chorioamnionitis 57 coronary revascularization 57 hemodialysis patients 57 prospectively defined 57 dose dose escalation 57 Histopathological 57 randomized Phase IIb 57 aneurysmal subarachnoid hemorrhage 57 advanced neoplasia 57 clinically evaluable 57 ONTARGET 57 dyslipidaemia 57 NCCTG N# 57 HF ACTION 57 ICSI cycles 57 CYPHER Stent 57 randomized multicenter 57 radical retropubic prostatectomy 57 bone scintigraphy 57 Baltimore Longitudinal Study 57 Collaborative Perinatal Project 57 pretransplant 57 oncologic outcomes 57 Wisconsin Sleep Cohort 57 efficacy evaluable 57 #F FDG PET 57 DAS# CRP 57 Angiographic 57 SORT OUT III 57 SLNB 57 ragweed allergic 57 Charlson Comorbidity Index 57 clinical pharmacology studies 57 MTWA testing 57 nodal metastases 57 endocrinologic 57 randomized Phase III 56 HSCT 56 renal transplantation 56 Logistic regression analysis 56 Cholesterol Levels SPARCL 56 VATS lobectomy 56 gastrectomy 56 undergoing bariatric surgery 56 Intervention Effectiveness 56 EVEREST II 56 LHRH receptor positive 56 FDG PET imaging 56 CAMMS# 56 transvaginal sonography 56 Patient Registry 56 patientswith 56 multicenter trials 56 Randomised Study 56 lipid lowering therapy 56 controlled dose escalation 56 Phase III randomized controlled 56 breast carcinoma 56 chlamydial infection 56 ABCSG 56 carotid artery stenting 56 unstable angina pectoris 56 CC genotype 56 LAGB 56 Multivariable logistic regression 56 pT2 56 radiographic examinations 56 SYNTAX 56 RTOG 56 LDLT 56 visceral metastases 56 APPRAISE 56 urothelial cancer 56 perioperative mortality 56 ECASS 56 generalizability 56 Diabetes Interventions 56 thyroidectomy 56 GH deficiency 56 multicenter randomized 56 Myocardial Infarction Study 56 GYTS 56 EUS FNA 56 null responder 56 obscure gastrointestinal bleeding 56 BR.# 56 EuroSCORE 56 adjuvant radiotherapy 56 NSTEMI 56 Dtsch Arztebl Int 56 atherothrombosis 56 cytologic 56 MGd 56 PLCO trial 56 ischemic cardiomyopathy 56 ASCUS 56 clinically localized prostate 56 null responder HCV 56 LV dysfunction 56 ABSORB trial 56 Radiation Therapy Oncology 56 malignant pleural mesothelioma 56 Univariate 56 acetabular fractures 56 ImmuKnow assay 56 coronary computed tomography 56 Meta analyzes 56 Tumor Registry 56 postmenopausal osteoporotic women 56 paclitaxel eluting stents 56 allogeneic hematopoietic stem cell 56 placebo controlled studies 56 leiomyomas 56 Observational studies 56 multivariate analysis 56 multivariable logistic regression 56 KIF6 gene variant 56 pancreatic adenocarcinoma 56 recurrent glioma 56 Health Initiative Observational 56 Evaluation WISE 56 Mayo Clinic Rochester MN 56 Poisson regression 56 definite stent thrombosis 56 multicenter Phase II 56 ACOSOG Z# 56 Feasibility Trial 56 metastatic HRPC 56 ER CHOP 56 REACH Registry 56 persistent pulmonary hypertension 56 calcaneal fractures 56 subthreshold depression 56 renal tumors 56 randomized multicenter Phase III 56 Logistic regression 56 randomized controlled multicenter 56 Spectranetics laser 56 Methods Retrospective 56 neoadjuvant 56 COR Analyzer 56 colorectal adenoma 56 metastatic neuroendocrine tumors 56 anal HPV 56 recurrent metastatic 56 study 56 Postoperative complications 56 journal Lancet Neurology 56 STICH trial 56 prostate cancer PCa 56 prelicensure 56 basal bolus regimen 56 ENDEAVOR clinical 56 Cornea Donor Study 56 multicenter clinical trials 56 Prospective Randomized 56 diagnostic laparoscopy 56 neuropathologic 56 axillary dissection 56 postoperative complication 56 TAXUS VI 56 RSD# oral 56 epidemiologic 56 Comorbidity 56 confounder 56 Chronic Heart Failure 56 AIM HIGH 56 carotid endarterectomy CEA 56 BEXXAR Therapeutic Regimen 56 Histologic 56 HIVNET 55 serologic testing 55 tumor histology 55 FDG PET CT 55 Neuroepidemiology 55 Histopathologic 55 Cohort Study MACS 55 nonpregnant women 55 VaD 55 TKAs 55 radical prostatectomy RP 55 nonfatal MI 55 EchoCRT 55 Communities ARIC Study 55 thoracic aortic disease 55 observational studies 55 pelvic ultrasound 55 APEX AMI trial 55 perioperative complications 55 NATRECOR ® 55 Acute myocardial infarction 55 peptic ulcer bleeding 55 laparoscopic radical nephrectomy 55 EORTC 55 retrospective observational 55 BPS IC 55 HPTN 55 #:#-# [031] 55 XIENCE V Stent System 55 adenoidectomy 55 BOLDER II 55 comorbid depression 55 malignant neoplasms 55 THIS STUDY analyzed 55 Coronary artery bypass grafting 55 lung resection 55 scintigraphic 55 recurrent venous thromboembolism 55 linear regression analyzes 55 NCT# ClinicalTrials.gov 55 vaginal hysterectomy 55 SLN biopsy 55 adrenalectomy 55 tipranavir ritonavir 55 serum lipid levels 55 histopathologic 55 KRAS status 55 sociodemographic characteristics 55 conventional angiography 55 ZACTIMA 55 spiral computed tomography 55 Phase III VISTA 55 QRISK 55 BRCA mutation carriers 55 histopathologic diagnosis 55 Renal Cell Carcinoma RCC 55 radiotherapy SBRT 55 asthma exacerbation 55 acute myeloid 55 pelvic lymph node dissection 55 dose escalation clinical 55 Intra operative 55 MR spectroscopy 55 noncardiac 55 incomplete revascularization 55 receiving antiretroviral therapy 55 Regression analyzes 55 Early Childhood Longitudinal Study 55 multicenter placebo controlled 55 genitourinary cancers 55 PET CT scans 55 singleton births 55 Cochrane Systematic Review 55 aldosterone antagonist 55 BRCA testing 55 journal Urology 55 hemodynamically significant 55 CYPHER R stent 55 journal Epilepsia 55 nonmetastatic 55 study1 55 MADIT CRT trial 55 genotypic resistance 55 multicenter randomized placebo controlled 55 pancreatectomy 55 esophageal resection 55 neurocognitive impairment 55 Heart Failure Trial 55 relapsed APL 55 abnormal cytology 55 conventional coronary angiography 55 genomewide 55 DEXA scan 55 perinatal mortality 55 RCTs 55 randomized clinical trials 55 colorectal neoplasia 55 stage IIIb IV 55 Women Ischemia Syndrome 55 hepatorenal syndrome 55 Thrombolysis 55 NLSY 55 fragility fractures 55 NSDUH 55 euthyroid 55 J Clin Oncol 55 seronegative 55 DAPT Study 55 subtrochanteric 55 CIN2 + 55 riociguat 55 miRview ™ mets 55 medically inoperable 55 nonvertebral fracture 55 Prospective Multicenter 55 schizophreniform disorder 55 randomized blinded placebo 55 Randomized Evaluation 55 Phase IIIb clinical 55 National Epidemiologic Survey 55 Multivariate analyzes 55 antipsychotic prescribing 55 carotid artery stenosis 55 allogeneic transplant 55 aged ≥ 55 immunocompetent 55 histologic subtype 55 operable breast cancer 55 ALLHAT 55 psoriatic arthritis PsA 55 RECORD1 55 myocardial infarction MI 55 preoperative chemotherapy 55 Decompensated Heart Failure 55 everolimus eluting stent 55 BRIM3 55 pharmacokinetic interaction 55 blinded randomized controlled 55 postmarketing adverse 55 endometriosis ovarian cysts 55 Myocardial Infarction 55 sonographic findings 55 Surgical Treatment 55 nonpsychotic 55 HIV seroconversion 55 BCIRG 55 Percutaneous Coronary Intervention 55 somatization disorder 55 computed tomography angiography 55 Carotid Endarterectomy 55 adjuvant tamoxifen 55 fluoroscopy guided 55 debulking surgery 55 chemoradiotherapy 55 multicentre randomized double 55 Oncophage vaccination 55 everolimus eluting stents 55 transcranial Doppler 55 HER2 expression 55 FDG PET 55 PIB PET 55 deCODE AF TM 55 Young Adults CARDIA 55 Study ARIC 55 transcranial Doppler ultrasound 55 Hodgkin lymphoma HL 55 blind placebo controlled 55 thyrotropin levels 55 CALGB # [002] 55 ADHERE 55 Aggressive Reduction 55 postdischarge 55 coronary artery bypass grafts 55 WHIMS 54 Sequenced Treatment Alternatives 54 Langerhans cell histiocytosis 54 OPTIMIZE HF 54 vertebral fracture 54 Arch Surg 54 MRSA colonization 54 Cancer Incidence 54 transthoracic echocardiography 54 allogeneic HSCT 54 advanced adenoma 54 ICD implants 54 biliary tract cancer 54 ROCKET AF 54 Brief Psychiatric 54 nonsevere 54 bicuspid aortic valves 54 placebo controlled clinical trials 54 Afib 54 anti arrhythmic drug 54 Acute Coronary Syndromes 54 proband 54 cerebral angiography 54 stratifying patients 54 mg BID dose 54 colorectal adenomas 54 antiretroviral naive 54 Kaplan Meier curve 54 colectomy 54 depressive symptomatology 54 symptomatic carotid stenosis 54 Cancer Epidemiol Biomarkers Prev 54 VTE prophylaxis 54 sacral neuromodulation 54 cytomegalovirus infection 54 etiologic 54 electrophysiologic 54 HeFH 54 INTERHEART 54 HIV seropositive 54 invasive aspergillosis 54 HealthCore 54 carotid surgery 54 immunohistochemical 54 APOE genotype 54 screening colonoscopy 54 immunohistochemical staining 54 femoral neck fracture 54 rFVIIa 54 premenopausal 54 Chicago Multidisciplinary Symposium 54 perfusion abnormalities 54 Radical prostatectomy 54 GISSI HF 54 histopathological 54 ATACAND 54 NSABP 54 Adjuvant chemotherapy 54 Clinicaltrials.gov 54 colorectal cancer incidence 54 Multicenter 54 CT colonography CTC 54 prospective randomized placebo 54 microdeletions 54 #:#-# [029] 54 fluvastatin 54 Subarachnoid hemorrhage 54 acute myocardial infarction MI 54 microscopic colitis 54 AVOREN 54 cryptogenic stroke 54 multicenter randomized double 54 arthroplasties 54 Interagency Registry 54 osteoid osteoma 54 Renal Data 54 androgen suppression 54 intracranial stenosis 54 HORIZONS AMI 54 narcolepsy cataplexy 54 Sipuleucel T 54 Pregnancy Registry 54 Risk Stratification 54 transabdominal 54 osteoporotic compression fractures 54 treatment naïve genotype 54 GnRH agonists 54 postmenopausal women 54 Randomized Controlled Trial 54 INTERCEPT platelets 54 coronary artery stenosis 54 journal Resuscitation 54 extracolonic findings 54 journal Rheumatology 54 dose escalation phase 54 MEND CABG 54 Acute Myocardial Infarction 54 suicide attempters 54 total hip arthroplasties 54 cirrhotic patients 54 PECARN 54 univariate analysis 54 abdominal hysterectomy 54 Statistical analyzes 54 PCI ExTRACT TIMI 54 normotensive 54 microbiologically evaluable 54 carotid atherosclerosis 54 landmark ATHENA trial 54 coexisting illnesses 54 Histological 54 prostate carcinoma 54 FDG PET scans 54 placebo controlled 54 Intravenous immunoglobulin 54 prospective multicenter randomized 54 spontaneous regression 54 Symptom severity 54 CYP#D# genotype 54 Replication NCS R 54 lipid abnormality 54 quadrivalent HPV vaccine 54 bladder augmentation 54 degenerative lumbar 54 ICD implantation 54 HCV RESPOND 2 54 USpella 54 logistic regression 54 perioperatively 54 drug eluting stent implantation 54 Multicenter Study 54 antithrombotic therapy 54 hematopoietic cancers 54 unstable angina UA 54 Cytogenetic 54 nomogram 54 antiphospholipid antibodies 54 Phase III randomized 54 nonobese 54 proliferative retinopathy 54 bilateral orchiectomy 54 FFR measurements 54 ductal carcinomas 54 SCD HeFT 54 SPARCL 54 Endeavor Resolute DES 54 HRCT 54 Nephrology Dialysis Transplantation 54 Angiogram 54 ToGA 54 MetS 54 percutaneous coronary interventions 54 portal vein thrombosis 54 RIO Lipids 54 Renal Artery 54 galiximab 54 DCCT 54 GWTG CAD 54 PRoFESS 54 histologic examination 54 transient elastography 54 placebo controlled dose escalation 54 International Verapamil SR 54 NIH CPSI 54 sociodemographic factors 54 Dietary Modification Trial 54 florbetaben 54 coronary arteriography 54 inconclusive Pap 54 APOL1 54 nonmetastatic prostate cancer 54 lymph node dissection 54 Multicentre 54 lipid lowering agents 54 ARIXTRA 54 anovulatory infertility 54 PCPT 54 chest radiography 54 Tumor Response 54 adverse perinatal 54 semistructured interviews 54 stable angina 54 onset atrial fibrillation 54 morphometric vertebral fractures 54 colorectal neoplasms 54 MGUS 54 postoperative radiotherapy 54 carotid revascularization 54 atrial fibrillation ablation 54 cardioembolic stroke 54 cranial irradiation 54 Heterozygous Familial Hypercholesterolemia 54 achieved sustained virological 54 XIENCE V PROMUS Stent 54 ALI ARDS 54 Cancer Prevention ATBC 54 Doppler echocardiography 54 Accelerated Partial Breast Irradiation 54 etiologic factors 54 Estrogen Receptor 54 #q# deletion 54 Xelox 54 Registry NOPR 54 postoperative mortality 54 thromboembolic 54 underwent angiography 54 % CI #.#-#.# [003] 54 genetic polymorphisms 54 RECIST Response Evaluation Criteria 54 revision hip arthroplasty 54 desvenlafaxine succinate 54 carotid artery stent 54 angiographic outcomes 54 thrombocytopenic 54 percutaneous vertebroplasty 54 Diabetologia 54 Genitourinary Cancers Symposium 54 prospectively 54 urothelial carcinoma 54 beta blocker therapy 54 AA Amyloidosis 53 liver biopsies 53 positron emission tomography scans 53 FluCAM arm 53 Sorafenib HCC Assessment 53 Longitudinal Study 53 venous thromboembolisms 53 breast cancer recurrences 53 postoperative chemotherapy 53 renal cell carcinomas 53 ASTEROID 53 total knee arthroplasties 53 KRAS mutations occur 53 ERSPC 53 ELBW 53 Peripheral Arterial 53 Diabetes Complications 53 biologic DMARDs 53 blinded randomized 53 phylogenetic analysis 53 neoadjuvant chemotherapy 53 Dr. Kandzari 53 subclinical atherosclerosis 53 KIF6 carriers 53 computed tomography scan 53 T1c 53 transfusion syndrome 53 mitral valve replacement 53 PROactive Study 53 invasive candidiasis 53 Mantel Haenszel 53 AIR CF3 53 atherosclerotic renal artery stenosis 53 post thrombotic syndrome 53 curative resection 53 LVNC 53 dosimetric 53 recurrent acute pancreatitis 53 CATIE AD 53 EURIDIS 53 pulmonary artery banding 53 noncardiac surgery 53 DXA scan 53 pharmacokinetic PK 53 radiofrequency catheter ablation 53 NHANES #-# 53 susceptibility loci 53 Interview Survey CHIS 53 Longitudinal studies 53 Transcatheter 53 shock wave lithotripsy 53 PRECiSE 53 revascularizations 53 cohort 53 OPT CHF 53 fundus photography 53 thromboembolic complications 53 NCI Surveillance Epidemiology 53 chemoradiation therapy 53 HCV antibody 53 Lancet Oncology journal 53 Doxil ® 53 ovarian endometrial 53 Liver biopsies 53 INSPIRE Trial Phase III 53 viral kinetic 53 NCCTG 53 Randomized Study 53 ENDEAVOR IV 53 pathologic examination 53 Randomized trials 53 psychiatric comorbidity 53 Venous Thromboembolism 53 endoscopic examinations 53 microsatellite instability 53 Renal Registry 53 blinded placebo controlled 53 DVT PE 53 Survey MEPS 53 functional neuroimaging 53 euthymic patients 53 randomized double 53 ICDs implanted 53 pretreatment serum 53 meta analytic review 53 differentiate squamous 53 CT angiograms 53 ipsilateral stroke 53 abacavir Ziagen 53 EDEMA3 trial 53 plain radiographs 53 coronary intervention 53 PERSEUS clinical program 53 AACR San Antonio 53 osteoporotic vertebral compression fractures 53 acute cholecystitis 53 MERIT ES 53 binary logistic regression 53 resectable pancreatic cancer 53 invasive lobular 53 BoNTA 53 chronic hemodialysis 53 adenoma recurrence 53 Histopathology 53 sonographic evaluation